Compare, Analyse SHASUN PHARMA with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SHASUN PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
TEVA PHARMA
Dec-13
SHASUN PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs942,980-   
Low Rs462,589-   
Sales per share (Unadj.) Rs214.21,710.2-  
Earnings per share (Unadj.) Rs5.3106.8-  
Cash flow per share (Unadj.) Rs15.8245.1-  
Dividends per share (Unadj.) Rs1.0093.52-  
Dividend yield (eoy) %1.43.4 42.6%  
Book value per share (Unadj.) Rs53.31,899.7-  
Shares outstanding (eoy) m56.62848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.6 20.0%   
Avg P/E ratio x13.126.1 50.3%  
P/CF ratio (eoy) x4.411.4 38.9%  
Price / Book Value ratio x1.31.5 89.4%  
Dividend payout %18.787.5 21.4%   
Avg Mkt Cap Rs m3,9582,361,010 0.2%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m2,1640-   
Avg. sales/employee Rs ThNM32,266.5-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,015.7-  
INCOME DATA
Net Sales Rs m12,1271,450,216 0.8%  
Other income Rs m2290-   
Total revenues Rs m12,3561,450,216 0.9%   
Gross profit Rs m1,009397,143 0.3%  
Depreciation Rs m594117,222 0.5%   
Interest Rs m41528,485 1.5%   
Profit before tax Rs m230251,436 0.1%   
Minority Interest Rs m01,142 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-165,054 0.0%   
Tax Rs m-73-3,070 2.4%   
Profit after tax Rs m30290,594 0.3%  
Gross profit margin %8.327.4 30.4%  
Effective tax rate %-31.7-1.2 2,593.1%   
Net profit margin %2.56.2 39.9%  
BALANCE SHEET DATA
Current assets Rs m6,884979,471 0.7%   
Current liabilities Rs m8,456854,181 1.0%   
Net working cap to sales %-13.08.6 -150.0%  
Current ratio x0.81.1 71.0%  
Inventory Days Days6291 67.9%  
Debtors Days Days10896 112.1%  
Net fixed assets Rs m4,970473,673 1.0%   
Share capital Rs m1133,570 3.2%   
"Free" reserves Rs m2,8750-   
Net worth Rs m3,0201,610,915 0.2%   
Long term debt Rs m1,817741,528 0.2%   
Total assets Rs m13,3473,314,209 0.4%  
Interest coverage x1.69.8 15.8%   
Debt to equity ratio x0.60.5 130.7%  
Sales to assets ratio x0.90.4 207.6%   
Return on assets %5.43.6 149.6%  
Return on equity %10.05.6 177.9%  
Return on capital %13.34.9 270.2%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Net fx Rs m3,6690-   
CASH FLOW
From Operations Rs m398231,089 0.2%  
From Investments Rs m-1,635-81,884 2.0%  
From Financial Activity Rs m1,309-277,207 -0.5%  
Net Cashflow Rs m71-128,002 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.39 Rs / USD

Compare SHASUN PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare SHASUN PHARMA With: DIVIS LABORATORIES  ALEMBIC LTD  UNICHEM LAB  CADILA HEALTHCARE  GSK PHARMA  



Today's Market

Sensex Ends above 39,000-Mark; Automobile and Banking Stocks Witness Buying(Closing)

Extending gains to the fifth day, Indian share markets rose sharply during the afternoon session and ended on a strong note.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - TTK HEALTHCARE COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS